Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.69 USD | +4.45% | -5.01% | +177.57% |
10/05 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
09/05 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+177.57% | 223.56Cr | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Vera Therapeutics Insider Bought Shares Worth $4,999,990, According to a Recent SEC Filing